What ceramide skin-benefit research actually shows

September 26, 2026

Part 2 of 5 · Ceramides for Formulators

Ceramides are part of the lipid matrix in the stratum corneum, the outer layer that helps limit water loss and restrict the entry of external substances. That gives ceramide-containing formulas a sound biological rationale. It does not mean that any ceramide powder, at any percentage, will produce a proven benefit when added to any cream. The evidence is strongest when we ask what was tested: a specific finished product, its vehicle, its lipid blend, the study population and the measured outcome.

Hydrated skin and water droplets representing ceramide skin-benefit evidence.

What human evidence can support

In a 2025 controlled study, 58 adults with dry skin and a history of eczema used two emollients for four weeks. The multivesicular emulsion containing glycerine and physiological lipids, including NP, AP, EOP, phytosphingosine and cholesterol, improved barrier integrity after tape stripping and reduced sensitivity to an irritant compared with baseline. The comparison emollient with glycerine improved hydration and dryness but did not show the same barrier-integrity result. This supports the potential of that complete lipid-containing product system; it cannot identify the effective percentage of each ceramide or prove that one ingredient caused the outcome. ^[4]

Why a percentage is not a universal answer

A human test cream study fixed Ceramide NP at 0.2% while investigating its combination with CerENP, a different acylceramide. The authors selected 0.2% because it was the lowest amount in their system associated with a modest but detectable barrier change. That is a useful NP benchmark for a development trial, not a universal optimum, a safety limit, or proof that 0.2% NP alone works in every base. ^[5]

Formulation state can change the result

Ceramides need to be incorporated into a suitable lipid structure. A 2024 review describes how incomplete dissolution and crystals formed during cooling or storage can reduce the performance seen in barrier models. In a porcine-skin model, adding ceramide crystals partly weakened the benefit of the otherwise ceramide-containing formula. Appearance is therefore not just a cosmetic issue: it can indicate that the intended lipid structure was not achieved. ^[1]

How to describe claims responsibly

For ingredient education, say that ceramides are used to develop barrier-supporting or moisturising formulas. Avoid promising treatment of eczema, dermatitis or other disease. For a finished product, substantiate claims on the actual formula and intended use. Evidence from a commercial multi-lipid emollient cannot be transferred directly to a new product containing a different grade, percentage, emulsifier or process.

What this means for formulators

The research supports well-designed ceramide-containing lipid systems. It does not supply one proven percentage for every subclass, grade and finished product.

Explore the JustGlow range

JustGlow Ceramide NP Powder | JustGlow Ceramide AP Powder | JustGlow Ceramide EOP Powder

Reader questions

What percentage of Ceramide NP has been tested in a human formula?

A human test-cream study used 0.2% NP in a system also investigating CerENP. Treat this as a study-specific benchmark, not a universal recommended dose.

Can a ceramide ingredient claim prove the finished cream works?

No. Claims need to match evidence for the finished formula and its use. Ingredient presence alone does not establish a clinical result.

Sources

Continue the series

Formulation information is educational. Confirm the processing requirements for your exact supplier grade and validate the stability and safety of each finished formula.